Beta-Blockers in the Management of Coronary Artery Disease: Are we on the Verge of a New Paradigm Shift?

E-ISSN： 2212-3962|9|1|11-21

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.9, Iss.1, 2014-06, pp. : 11-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers

By Marie P.-Y. Mertes P.M. Hassan-Sebbag N. de Talence N. Djaballah K. Djaballah W. Friberg J. Olivier P. Karcher G. Zannad F. Bertrand A.

Journal of the American College of Cardiology, Vol. 43, Iss. 3, 2004-02 ,pp. : 353-359

Elsevier

Access to resources Recommend Favorite

Clinical utility of β-blockers for primary and secondary prevention of coronary artery disease

By Calhoun McKenzie Cross L Brian Cooper-DeHoff Rhonda M

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 289-291

Informa Healthcare

Access to resources Recommend Favorite

Diagnosis and Management of Chronic Coronary Artery Disease

Current Cardiology Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 221-231

Bentham Science Publishers

Access to resources Recommend Favorite

Future strategies in the management of coronary artery disease

By Schwitter Jürg

Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. : 555-566

Future Medicine

Access to resources Recommend Favorite

Coronary artery disease management with ivabradine in clinical practice

By Pinto Fausto J.

European Heart Journal Supplements, Vol. 13, Iss. 1, 2011-09 ,pp. : 25-29

Oxford University Press

Access to resources Recommend Favorite